Regulated expression of MUC1 epithelial antigen in erythropoiesis

British Journal of Haematology

Volumn 120, Issue 2, 2003, Pages 344-352

  Rughetti, Aurelia ^a   Biffoni, Mauro ^a   Pierelli, Luca ^d   Rahimi, Hassan ^a   Bonanno, Giuseppina ^d   Barachini, Serena ^a   Pellicciotta, Ilenia ^a   Napoletano, Chiara ^a   Pescarmona, Edoardo ^a   Del Nero, Angelo ^a   Pignoloni, Patrizia ^b   Frati, Luigi ^c   Nuti, Marianna ^a,d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ROMAIL Haematology   (Italy)

^c IRCCS NEUROMED   (Italy)

^d Dept of Exp Medicine/Pathology ^*

Author keywords

Cell cell interaction; Erythropoiesis; Haematopoiesis; MUC1; Sialoadhesin

Indexed keywords

CD34 ANTIGEN; CELL MARKER; EPITHELIAL MEMBRANE ANTIGEN; GLYCOPHORIN A; GLYCOPROTEIN; MUCIN 1; SIALOADHESIN;

ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL INTERACTION; CELL LINEAGE; CONTROLLED STUDY; EPITHELIUM CELL; ERYTHROBLAST; ERYTHROCYTE; ERYTHROID CELL; ERYTHROPOIESIS; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MACROPHAGE; MEGAKARYOPOIESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANTIGENS, CD34; BIOLOGICAL MARKERS; BLOTTING, WESTERN; BONE MARROW CELLS; CELL ADHESION; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELLS, CULTURED; ERYTHROPOIESIS; FLOW CYTOMETRY; GLYCOPHORIN; GRANULOCYTES; HUMANS; IMMUNOENZYME TECHNIQUES; MEGAKARYOCYTES; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; PHOSPHORYLATION; RECEPTORS, IMMUNOLOGIC;

EID: 0037278398     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04038.x     Document Type: Article

References (43)

1. Acres, R.B., Hareuveni, M., Balloul, J.M. & Kieny, M.P. (1993) Vaccinia virus MUC1 immunization of mice: immune response and protection against the growth of murine tumors bearing the MUC1 antigen. Journal of Immunotherapy, 14, 136-143.
2. Agrawal, B., Gendler, S.J. & Longenecker, B.M. (1998a) The biological role of mucins in cellular interactions and immune regulation: prospects for cancer immunotherapy. Molecular Medicine Today, 4, 397-403.
3. Agrawal, B., Krantz, M.J., Parker, J. & Longenecker, B.M. (1998b) Expression of MUC1 mucin on activated human T cells: implication for a role of MUC1 in normal immune regulation. Cancer Research, 58, 4079-4081.
4. Baeckstrom, D., Nilsson, O., Price, M.R., Lindholm, L. & Hansson, G.C. (1993) Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody. Cancer Research, 53, 755-761.
5. Baruch, A., Hartmann, M., Zrihan-Licht, S., Greenstein, S., Burstein, M., Keydar, I., Weiss, M., Smorodinsky, N. & Wreschner, D.H. (1997) Preferential expression of novel MUC1 tumor antigen isoforms in human epithelial tumors and their tumor-potentiating function. International Journal of Cancer, 71, 741-749.
6. ten Berge, R.L., Snijdewint, F.G., von Mensdorff-Pouilly, S., Poort-Keesom, R.J., Oudejans, J.J., Meijer, J.W., Willemze, R., Hilgers, J. & Meijer, C.J. (2001) MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form. Journal of Clinical Pathology, 54, 933-939.
7. Brossart, P., Schneider, A., Dill, P., Schammann, T., Grunebach, F., Wirths, S., Kanz, L., Buhring, H.J. & Brugger, W. (2001) The epithelial tumor antigen MUC1 is expressed in haematological malignancies and is recognised by MUC1-specific cytotoxic T-lymphocytes. Cancer Research, 61, 6846-6850.
8. Brugger, W., Buhring, H.-J., Grunebach, F., Vogel, W., Kaul, S., Muller, R., Brummendorf, T.H., Ziegler, B.L., Rappold, I., Brossart, P., Scheding, S. & Kanz, L. (1999) Expression of MUC1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells. Journal of Clinical Oncology, 17, 1535-1544.
9. Burchell, J. & Taylor-Papadimitriou, J. (1993) Effect of modification of carbohydrate side chains on the reactivity of antibodies with core protein-epitopes of the MUC1 gene product. Epithelial Cell Biology, 2, 155-162.
10. Burchell, J., Durbin, H. & Taylor-Papadimitriou, J. (1983) Complexity of expression of antigenic determinants, recognised by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells. Journal of Immunology, 131, 508-513.
11. Burchell, J.M., Mungul, A. & Taylor-Papadimitriou, J. (2001) O-linked glycosylation in the mammary gland: changes that occur during malignancy. Journal of Mammary Gland Biology and Neoplasia, 6, 355-364.
12. Dent, G.A., Civalier, C.J., Brecher, M.E. & Bentley, S.A. (1999) MUC1 expression in haematopoietic tissues. American Journal of Clinical Pathology, 111, 741-747.
13. Gaemers, I.C., Vos, H.L., Volders, H.H., van der Valk, S.W. & Hilkens, J. (2001) A stat-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells. Journal of Biological Chemistry, 276, 6191-6199.
14. Gendler, S.J. (2001) MUC1, the renaissance of a molecule. Journal of Mammary Gland Biology and Neoplasia, 6, 339-352.
15. Gendler, S., Duhig, T., Lamport, D., White, R., Parker, M. & Taylor-Papadimitriou, J. (1987) Cloning of partial cDNA encoding differentiation antigen and tumor associated mucin glycoproteins expressed by human epithelia. Procedings of the National Academy of Sciences of the United States of America, 84, 6060-6064.
16. Hilkens, J. & Boer, M. (1998) Monoclonal antibodies against the non mucin domain of MUC1/episialin. Tumour Biology, 19, 67-70.
17. Hilkens, J., Ligtenberg, M.J., Vos, H.L. & Litinov, S.V. (1992) Cell membrane-associated mucins and their adhesion-modulating property. Trends in Biochemical Science, 17, 359-363.
18. Hoang, T., Paradis, E., Brady, G., Billia, F., Nakahara, K., Iscove, N.N. & Kirsch, I.R. (1996) Opposing effects of the basic helix-loop-helix transcription factor SCL on erythroid and monocytic differentiation. Blood, 87, 102-111.
19. Kam, J.L., Regimbald, L.H., Hilgers, J.H.M., Hoffman, P., Krantz, M.J., Longenecker, B.M. & Hugh, J.C. (1998) MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats. Cancer Research. 58, 5577-5581.
20. Kirito, K., Nakajima, K., Watanabe, T., Uchida, M., Tanaka, M., Ozawa, K. & Komatsu, N. (2002) Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation. Blood, 99, 3220-3227.
21. Kjeldsen, T., Clausen, H., Hirohashi, S., Ogawa, T., Iijima, H. & Hakomori, S. (1988) Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2-6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Research, 48, 2214-2220.
22. McDermott, K.M., Crocker, P.R., Harris, A., Burdick, M.D., Hinoda, Y., Hayashi, T., Imai, K. & Hollingswort, M.A. (2001) Overexpression of MUC1 reconfigures the binding properties of tumor cells. International Journal of Cancer, 94, 783-791.
23. McGuckin, M.C., Golder, J. & McKenzie, I.F.C. (2000) Muc1 (Cd227). Leukocyte Typing VII. Oxford University Press, Oxford.
24. Mainiero, F., Gismondi, A., Milella, M., Morrone, S., Palmieri, G., Piccoli, M., Frati, L. & Santoni, A. (1994) Long term activation of natural killer cells results in modulation of beta 1-integrin expression and function LFA-1. Journal of Immunology, 152, 446-454.
25. von Mensdorff-Pouilly, S., Snijdewint, F.G., Verstraeten, A.A., Verheijen, R.H. & Kenemans, P. (2000) Human MUC1 mucin: a multifaceted glycoprotein. International Journal of Biological Markers, 15, 343-356.
26. Nath, D., Hartnell, A., Happerfiel, L., Miles, D.W., Burchell, J., Taylor-Papadimitriou, J. & Crocker, P.R. (1999) Macrophage-tumor cell interactions: identification of MUC1 on breast cancer cells as a potential counterreceptor for the macrophage-restricted receptor, sialoadhesin. Immunology, 98, 213-219.
27. Patton, S., Gendler, S.J. & Spicer, A.P. (1995) The epithelial mucin, MUC1, of milk, mammary gland and other tissues. Biochimical and Biophysica Acta, 1241, 407-423.
28. Pemberton, L., Taylor-Papadimitriou, J. & Gendler, S.J. (1992) Antibodies to the cytoplasmic domain of the MUC1 mucin show conservation throughout mammals. Biochemical and Biophysical Research Communications, 185, 167-175.
29. + haematopoietic progenitors. British Journal of Haematology, 102, 1139-1150.
30. Quin, R.J. & McGuckin, M.A. (2000) Phosphorylation of the cytoplasmic domain of the MUC1 mucin correlates with changes in cell-cell adhesion. International Journal of Cancer, 87, 499-506.
31. Regimbald, L.H., Pilarski, L.M., Longenecker, B.M., Reddish, M.A., Zimmermann, G. & Hugh, J.C. (1996) The breast mucin MUC1 as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. Cancer Research, 56, 4244-4249.
32. Ren, J., Li, Y. & Kufe, D. (2002) Protein kinase C delta regulates function of the DF3/ MUC1 carcinoma antigen in beta-catenin signaling. Journal of Biological Chemistry, 277, 17616-17622.
33. Schroeder, J.A., Thompson, M.C., Gardner, M.M. & Gendler, S.J. (2001) Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland. Journal of Biological Chemistry, 276, 13057-13064.
34. Scibetta, A.G., Albanese, I., Morris, J., Cooper, L., Downward, J., Rowe, P.P. & Taylor-Papadimitriou, J. (2001) Regulation of MUC1 expression in human mammary cell lines by the c-ErbB2 and ras signaling pathways. DNA and Cell Biology, 20, 265-274.
35. + cells. Journal of Experimental Medicine, 183, 837-845.
36. Sutherland, J.A., Turner, A.R., Mannoni, P., McGann, L.E. & Turc, J.M. (1986) Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages. Journal of Biological Response Modification, 5, 250-262.
37. Taylor-Papadimitriou, J., Burchell, J., Miles, D.W. & Dalziel, M. (1999) MUC1 and cancer. Biochimica et Biophysica Acta, 1455, 301-313.
38. Treon, S.P., Maimonis, P., Bua, D., Young, G., Raje, N., Mollick, J., Chauhan, D., Tai, Y.T., Hideshima, T., Shima, Y., Hilgers, J., von Mensdorff-Pouilly, S., Belch, A.R., Pilarski, L.M. & Anderson, K.C. (2000a) Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma. Blood, 96, 3147-3153.
39. Treon, S.P., Raje, N. & Anderson, K.C. (2000b) Immunotherapeutic strategies for the treatment of plasma cell malignancies. Seminars in Oncology, 27, 598-613.
40. Vinson, M., van der Merwe, P.A., Kelm, S., May, A., Jones, E.Y. & Crocker, P.R. (1996) Characterization of the sialic acid-binding site in sialoadhesin by site-directed mutagenesis. Journal of Biological Chemistry, 271, 9267-9272.
41. Wesseling, J., van der Walk, S.W., Vos, H.L., Sonnenberg, A. & Hilkens, J. (1995) Epsialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. Journal of Cell Biology, 129, 255-265.
42. Wykes, M., MacDonald, K.P.A., Tran, M., Quin, R.J., Xing, P.X., Gendler, S.J., Hart, D.N.J. & McGuckin, M.A. (2002) MUC1 epithelial mucin (CD227) is expressed by activated dendritic cells. Journal of Leukocyte Biology, 72, 692-701.
43. Yamamoto, M., Bharti, A., Li, Y. & Kufe, D. (1997) Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion. Journal of Biological Chemistry, 272, 12492-12494.